Breakpoint Therapeutics

company

About

Breakpoint Therapeutics is a company that discover and develop new anti-cancer drugs.

  • 1 - 10

Details

Last Funding Type
Series Unknown
Last Funding Money Raised
€30M
Industries
Biotechnology,Health Care,Therapeutics
Founded date
Jan 1, 2019
Number Of Employee
1 - 10
Operating Status
Active

Breakpoint Therapeutics is a company that discover and develop new anti-cancer drugs. By targeting the DNA damage response (“DDR”) in cancer cells, Breakpoint Therapeutics aims to advance to clinical development first-in-class oncology drugs that interfere with DNA repair and replication stress tolerance pathways. Their mission is to develop drugs that succeed and complement PARP inhibitors and facilitate the cure of therapy resistant cancers.

Funding Rounds

Number of Funding Rounds
Total Funding Amount
1
€30M
Breakpoint Therapeutics has raised a total of €30M in funding over 2 rounds. Their latest funding was raised on Jul 9, 2019 from a Series Unknown round.
Announced Date Round Money Raised Number of Investors Lead Investors Post Valuation
Jul 9, 2019 Series Unknown €30M 1 Detail

Investors

Number of Lead Investors
Number of Investors
1
Breakpoint Therapeutics is funded by 1 investors. Evotec are the most recent investors.
Investor Name Lead Investor Funding Round
Evotec Series Unknown